Amneal Pharmaceuticals In... (AMRX)
NASDAQ: AMRX
· Real-Time Price · USD
9.27
-0.18 (-1.90%)
At close: Aug 18, 2025, 3:59 PM
9.10
-1.83%
After-hours: Aug 18, 2025, 07:40 PM EDT
-1.90% (1D)
| Bid | 9.06 |
| Market Cap | 2.91B |
| Revenue (ttm) | 2.85B |
| Net Income (ttm) | 3.38M |
| EPS (ttm) | 0.01 |
| PE Ratio (ttm) | 927 |
| Forward PE | 9.48 |
| Analyst | Buy |
| Ask | 9.6 |
| Volume | 1,041,673 |
| Avg. Volume (20D) | 1,898,016.1 |
| Open | 9.39 |
| Previous Close | 9.45 |
| Day's Range | 9.27 - 9.46 |
| 52-Week Range | 6.68 - 9.59 |
| Beta | 1.12 |
About AMRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AMRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AMRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Amneal Pharmaceuticals Inc. is scheduled to release its earnings on
Nov 7, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
+2.14%
Amneal Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
2 weeks ago
-0.25%
Shares of several biotechnology stocks are trading higher amid Vinay Prasad's departure as director of the FDA's Center for Biologics Evaluation and Research.
2 weeks ago · fool.com
Amneal (AMRX) Q2 EPS Jumps 56%Amneal (AMRX) Q2 EPS Jumps 56%
2 weeks ago · seekingalpha.com
Amneal Pharmaceuticals, Inc. (AMRX) Q2 2025 Earnings Call TranscriptAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX ) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants Anastasios G. Konidaris - Executive VP & CFO Anthony DiMeo - Head of Investo...
